204 related articles for article (PubMed ID: 15701648)
1. Potent glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth in vitro.
Vyas AA; Blixt O; Paulson JC; Schnaar RL
J Biol Chem; 2005 Apr; 280(16):16305-10. PubMed ID: 15701648
[TBL] [Abstract][Full Text] [Related]
2. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.
Pan B; Fromholt SE; Hess EJ; Crawford TO; Griffin JW; Sheikh KA; Schnaar RL
Exp Neurol; 2005 Sep; 195(1):208-17. PubMed ID: 15953602
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides are neuronal ligands for myelin-associated glycoprotein.
Yang LJ; Zeller CB; Shaper NL; Kiso M; Hasegawa A; Shapiro RE; Schnaar RL
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):814-8. PubMed ID: 8570640
[TBL] [Abstract][Full Text] [Related]
4. Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides.
Sun J; Shaper NL; Itonori S; Heffer-Lauc M; Sheikh KA; Schnaar RL
Glycobiology; 2004 Sep; 14(9):851-7. PubMed ID: 15175257
[TBL] [Abstract][Full Text] [Related]
5. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells.
Mehta NR; Lopez PH; Vyas AA; Schnaar RL
J Biol Chem; 2007 Sep; 282(38):27875-86. PubMed ID: 17640868
[TBL] [Abstract][Full Text] [Related]
6. Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration.
Vyas AA; Schnaar RL
Biochimie; 2001 Jul; 83(7):677-82. PubMed ID: 11522397
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration.
Vyas AA; Patel HV; Fromholt SE; Heffer-Lauc M; Vyas KA; Dang J; Schachner M; Schnaar RL
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8412-7. PubMed ID: 12060784
[TBL] [Abstract][Full Text] [Related]
8. Enhanced binding of the neural siglecs, myelin-associated glycoprotein and Schwann cell myelin protein, to Chol-1 (alpha-series) gangliosides and novel sulfated Chol-1 analogs.
Collins BE; Ito H; Sawada N; Ishida H; Kiso M; Schnaar RL
J Biol Chem; 1999 Dec; 274(53):37637-43. PubMed ID: 10608819
[TBL] [Abstract][Full Text] [Related]
9. High affinity sialoside ligands of myelin associated glycoprotein.
Zeng Y; Rademacher C; Nycholat CM; Futakawa S; Lemme K; Ernst B; Paulson JC
Bioorg Med Chem Lett; 2011 Sep; 21(17):5045-9. PubMed ID: 21561770
[TBL] [Abstract][Full Text] [Related]
10. Brain gangliosides in axon-myelin stability and axon regeneration.
Schnaar RL
FEBS Lett; 2010 May; 584(9):1741-7. PubMed ID: 19822144
[TBL] [Abstract][Full Text] [Related]
11. Examination of the biological role of the alpha(2-->6)-linked sialic acid in gangliosides binding to the myelin-associated glycoprotein (MAG).
Schwardt O; Gäthje H; Vedani A; Mesch S; Gao GP; Spreafico M; von Orelli J; Kelm S; Ernst B
J Med Chem; 2009 Feb; 52(4):989-1004. PubMed ID: 19175312
[TBL] [Abstract][Full Text] [Related]
12. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition.
Vinson M; Strijbos PJ; Rowles A; Facci L; Moore SE; Simmons DL; Walsh FS
J Biol Chem; 2001 Jun; 276(23):20280-5. PubMed ID: 11279053
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory activity of myelin-associated glycoprotein on sensory neurons is largely independent of NgR1 and NgR2 and resides within Ig-Like domains 4 and 5.
Wörter V; Schweigreiter R; Kinzel B; Mueller M; Barske C; Böck G; Frentzel S; Bandtlow CE
PLoS One; 2009; 4(4):e5218. PubMed ID: 19367338
[TBL] [Abstract][Full Text] [Related]
14. Myelin-associated glycoprotein and its axonal receptors.
Schnaar RL; Lopez PH
J Neurosci Res; 2009 Nov; 87(15):3267-76. PubMed ID: 19156870
[TBL] [Abstract][Full Text] [Related]
15. Myelin-associated glycoprotein in myelin and expressed by Schwann cells inhibits axonal regeneration and branching.
Shen YJ; DeBellard ME; Salzer JL; Roder J; Filbin MT
Mol Cell Neurosci; 1998 Sep; 12(1-2):79-91. PubMed ID: 9770342
[TBL] [Abstract][Full Text] [Related]
16. The inhibition site on myelin-associated glycoprotein is within Ig-domain 5 and is distinct from the sialic acid binding site.
Cao Z; Qiu J; Domeniconi M; Hou J; Bryson JB; Mellado W; Filbin MT
J Neurosci; 2007 Aug; 27(34):9146-54. PubMed ID: 17715351
[TBL] [Abstract][Full Text] [Related]
17. Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells.
Collins BE; Fralich TJ; Itonori S; Ichikawa Y; Schnaar RL
Glycobiology; 2000 Jan; 10(1):11-20. PubMed ID: 10570219
[TBL] [Abstract][Full Text] [Related]
18. Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein.
DeBellard ME; Tang S; Mukhopadhyay G; Shen YJ; Filbin MT
Mol Cell Neurosci; 1996 Feb; 7(2):89-101. PubMed ID: 8731478
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid specificity of myelin-associated glycoprotein binding.
Collins BE; Yang LJ; Mukhopadhyay G; Filbin MT; Kiso M; Hasegawa A; Schnaar RL
J Biol Chem; 1997 Jan; 272(2):1248-55. PubMed ID: 8995428
[TBL] [Abstract][Full Text] [Related]
20. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.
Venkatesh K; Chivatakarn O; Lee H; Joshi PS; Kantor DB; Newman BA; Mage R; Rader C; Giger RJ
J Neurosci; 2005 Jan; 25(4):808-22. PubMed ID: 15673660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
